Cybin to participate in water tower research fireside chat on december 11, 2024

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, and amir inamdar, mbbs, dnb (psych), ffpm, cybin's chief medical officer, will participate in the water tower research fireside chat series taking place.
CYBN Ratings Summary
CYBN Quant Ranking